Javelin Pharmaceuticals, Inc

(AMEX:JAV)
  Sep 30, 2008 Jun 30, 2008 Mar 31, 2008 Dec 31, 2007
Assets
Current Assets
Cash & Equivalents 34,665 41,628 22,243 15,931
Restricted Cash — — — —
Marketable Securities — 2,975 4,975 21,319
Accounts Receivable 368 158 62 —
Loans Receivable — — — —
Other Receivable — — — —
Receivables 368 158 62 —
Raw Materials — — — —
Work in Progress — 731 584 —
Purchased Components — — — —
Finished Goods — 1,024 83 —
Other Inventories 2,039 — — 116
Inventories Adjustments and Allowances — — — —
Inventories 2,039 1,756 667 116
Prepaid Expenses 523 630 1,313 1,290
Current Deferred Income Taxes — — — —
Other Current Assets — — — —
Total Current Assets 37,595 47,147 29,260 38,656
Land and Improvements — — — —
Building and Improvements — — — 5
Machinery Furniture and Equipment — — — 494
Construction in Progress — — — 273
Other Fixed Assets 1,544 1,282 1,255 43
Total Fixed Assets 1,544 1,282 1,255 816
Gross Fixed Assets 1,544 1,282 1,255 816
Accumulated Depreciation and Depletion 270 270 270 270
Net Fixed Assets 1,274 1,011 985 545
Intangibles 3,627 3,683 3,739 3,796
Cost in Excess — — — —
Non Current Deferred Income Taxes — — — —
Other Non Current Assets 1,957 158 158 154
Total Non Current Assets 6,858 4,852 4,882 4,495
Total Assets 44,453 51,999 34,142 43,152
Liabilities
Current Liabilities
Accounts Payable 10,166 7,779 7,759 1,432
Notes Payable — — — —
Short Term Debt — — — —
Accrued Expenses — — — 259
Accrued Liabilities — — — 6,466
Deferred Revenues — — — —
Current Deferred Income Tax Liabilities — — — —
Other Current Liabilities 541 565 587 484
Total Current Liabilities 10,706 8,344 8,347 8,641
Non Current Liabilities
Long Term Debt — — — —
Capital Lease Obligations — — — —
Deferred Income Tax Liabilities — — — —
Other Non Current Liabilities — — — —
Minority Interest Liabilities — — — —
Preferred Securities of Subsidiary Trust Liabilities — — — —
Preferred Equity Outside Stock Equity — — — —
Total Non Current Liabilities 10,706 8,344 8,347 8,641
Total Liabilities — — — —
Shareholders' Equity
Preferred Stock Equity — — — —
Common Stock Equity 33,747 43,655 25,795 34,511
Common Par 61 61 49 49
Additional Paid in Capital 173,843 172,918 145,989 144,923
Cumulative Translation Adjustment — — — —
Retained Earnings -140,173 -129,302 -120,243 -110,470
Treasury Stock — — — —
Other Equity Adjustments 16 -21 — 9
Total Capitalization 33,747 43,655 25,795 34,511
Cash Flow -38,969 -36,441 -34,729 -30,932
Working Capital 26,889 38,803 20,913 30,015
Free Cash Flow -27,087 -18,955 -10,287 -27,336
Invested Capital 33,747 43,655 25,795 34,511
Total Equity 33,747 43,655 25,795 34,511
Total Liabilities and Stock Equity 44,453 51,999 34,142 43,152